Amgen appointed Naveen Gullapalli, former Novartis executive, as Managing Director of Amgen India. Gullapalli will lead Amgen ...

Naveen Gullapalli has been appointed as Managing Director of Amgen's India Technology and Innovation Hub in Hyderabad, ...

Gullapalli will oversee the Amgen India Technology and Innovation hub, leveraging his extensive expertise in global ...

Amgen appoints Naveen Gullapalli as managing director to accelerate tech & innovation from India: Our Bureau, Bengaluru ...

Amgen (NASDAQ: AMGN) offers an intriguing test case for this dynamic heading into 2025. The biotech-giant's shares have slumped 3.37% in 2024, while the S&P 500 has surged 26.8% as of this writing ...

An Amgen manufacturing facility in Thousand Oaks, California. In 2025, the company plans to open a manufacturing site in Holly Springs, North Carolina. DANIEL HENNESSY Photo courtesy of Amgen The ...

Amgen Inc (Symbol: AMGN) presently has an excellent rank, in the top 25% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

(RTTNews) - Amgen (AMGN) announced new data from a Phase 3 study demonstrating that adding BLINCYTO (blinatumomab) to chemotherapy significantly improves disease-free survival (DFS) in newly ...

Amgen, headquartered in California, is a publicly traded company and one of 30 in the Dow Jones Industrial, according to a state news release. It has more than 27,000 employees globally.

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best affordable stocks to buy. There has been a growing debate regarding whether the economy of ...

(RTTNews) - Amgen, Inc. (AMGN) announced Thursday a $1 billion expansion to establish a second drug substance manufacturing facility in North Carolina. This brings the company's total planned ...